Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Iloprost in COPD
NCT01941225Phase 2Completed
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Sep 2013
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Inhaled iloprost 5.0 mcg with Placebo (2 arms). Primary endpoint: Dynamic hyperinflation during maximal cardiopulmonary exercise test at 30 months. Started Sep 2013; status: completed.
02
Drugs
iloprost
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01941225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941225.